The effects of bupivacaine and neostigmine on articular cartilage and synovium in the rabbit knee joint


Dogan N., ERDEM A. F., ERMAN Z., KIZILKAYA M.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, cilt.32, sa.5, ss.513-519, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 5
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1177/147323000403200509
  • Dergi Adı: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.513-519
  • Anahtar Kelimeler: bupivacaine, neostigmine, anaesthetics, intra-articular analgesia, articular cartilage, synovial membrane, knee joint, histopathological changes, POSTOPERATIVE ANALGESIA, INTRAARTICULAR INJECTION, PAIN CONTROL, ARTHROSCOPY, MORPHINE, KETOROLAC, SURGERY, METHYLSULFATE, SAFETY
  • Atatürk Üniversitesi Adresli: Evet

Özet

We investigated the effects of intra-articular injections of bupivacaine and neostigmine on articular cartilage and the synovial membrane of rabbit knee joints. Saline, bupivacaine or neostigmine were each administered intra-articularly into 15 knee joints. Five joints per drug treatment were prepared for histopathological examination 24 h, 48 h and 10 days after injection. A pathologist examined the histological samples for inflammation of the articular cartilage, inflammatory cell infiltration, hypertrophy and hyperplasia of the synovial membrane, in a blinded manner. There were no histopathological changes in the saline-treated control joints. joints treated with bupivacaine and neostigmine showed significantly more histopathological changes than control joints. joints treated with neostigmine showed significantly more histopathological changes than those treated with bupivacaine, except for articular cartilage inflammation on day 10. We conclude that intra-articular bupivacaine and neostigmine cause histopathological changes in rabbit knee joints, with neostigmine having a greater effect than bupivacaine.